Applied BioCode Corporation (TPE:6598)
Taiwan · Delayed Price · Currency is TWD 23.35
-0.20 (-0.85%)
At close: Mar 27, 2026
Applied BioCode Revenue
In the year 2025, Applied BioCode had annual revenue of 475.20M TWD with 38.52% growth. Applied BioCode had revenue of 116.50M in the quarter ending December 31, 2025, with 37.08% growth.
Revenue
475.20M
Revenue Growth
+38.52%
P/S Ratio
5.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 475.20M | 132.13M | 38.52% |
| Dec 31, 2024 | 343.07M | -52.10M | -13.18% |
| Dec 31, 2023 | 395.17M | 4.87M | 1.25% |
| Dec 31, 2022 | 390.30M | 70.34M | 21.98% |
| Dec 31, 2021 | 319.96M | 20.95M | 7.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.40B |
| OK Biotech | 1.56B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| Bioptik Technology Incorporation | 837.19M |
| A Plus Biotechnology | 835.89M |
| Diamond Biotechnology | 698.11M |